Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review

Título:

Autor:

Antônio Rodrigues Braga Neto

Ano:

2015

DOI:

10.1111/1471-0528.13617

Revista:

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

ISSN:

14700328

Tags:

Hormonal contraceptive

Gestational trophoblastic disease

gestational trophoblastic neoplasia

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

Infecção pelo citomegalovírus na gestação: uma visão atual

Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend

Perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia: a systematic review of observational studies and meta-analysis

Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?

Perfil da paciente que opta por inserir dispositivo intra-uterino no Núcleo de Planejamento Familiar da Faculdade de Medicina de Valença.

Perinatal outcome impact of prenatal care on hypertensive pregnant women

Gestational Trophoblastic Disease in Brazil

Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia

Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?

Leucorréia: uma queixa frequente